Skip to content
Stem cell section cover: a glowing stem cell cluster on a black background

Stroke and cerebrovascular disease: what Cheongdam Cell Clinic mentions

Stroke among the 'difficult to cure diseases' the clinic references

Quick answer

Cheongdam Cell Clinic mentions cerebrovascular disorder and stroke among the 'difficult to cure diseases' its 淸(Rejuvenation)CELL programme is presented alongside. Stroke, however, is a medical emergency requiring immediate hospital treatment by a neurology team when acute symptoms occur. Stem-cell therapy for post-stroke recovery remains largely within clinical research worldwide and is not a standard treatment that replaces conventional rehabilitation.

Key facts

Related programme
淸(Rejuvenation)CELL
Stroke types
Ischemic and hemorrhagic
Emergency care
Hospital with a neurology team
Stem-cell evidence
Mostly still at clinical-trial stage
Core of recovery
Physical and occupational therapy

The English description of the 淸(Rejuvenation)CELL programme on Cheongdam Cell Clinic's official site lists 'stroke' and 'cerebrovascular disorder' under a group it calls 'difficult to cure diseases', alongside dementia, atopy, psoriasis and autoimmune disease — a broad grouping of very different conditions under a shared cell-and-immune-regeneration rationale.

Stroke divides into two main types: ischemic stroke (blockage) and hemorrhagic stroke (bleeding). Both are emergencies requiring brain imaging such as CT or MRI and treatment by a neurology team within a narrow time window to minimise brain damage. Stem-cell therapy cannot substitute for this emergency care.

Global research on stem cells for post-stroke recovery continues, aiming to help repair damaged brain tissue in patients past the acute phase. However, most studies remain at the clinical-trial stage and have not been endorsed as standard treatment by major international neurology societies. Rehabilitation therapy — physical, speech and occupational therapy — remains the core of post-stroke care.

Cheongdam Cell Clinic's website does not indicate a dedicated neurology department or stroke-rehabilitation unit. The 淸(Rejuvenation)CELL programme is a whole-body intravenous stem-cell injection aimed at anti-ageing and general immune support, rather than a specialised post-stroke brain-rehabilitation programme.

Patients with a history of stroke who are stable and interested in this programme for general vascular support should bring recent brain-imaging results, treatment history, any blood-thinning medication in use, and their neurologist's opinion for Cheongdam Cell Clinic to review, since blood thinners can affect bleeding risk from stem-cell injection.

Anyone with warning signs of stroke — sudden limb weakness, slurred speech, or facial drooping on one side — must go to the nearest hospital immediately. They should not wait for an appointment or travel to any beauty or anti-ageing clinic, since every minute affects the extent of brain damage.

In summary, the mention of stroke on Cheongdam Cell Clinic's website should be understood strictly in the context of supplementary long-term vascular support for already-stable patients, not as emergency treatment or a replacement for standard rehabilitation.

Frequently asked questions

  • Can stem cells treat acute stroke?

    No. Acute stroke requires immediate hospital treatment by a neurology team; stem cells are not an emergency treatment.

  • Can a stable post-stroke patient take this programme?

    Bring brain-imaging results and a neurologist's opinion for the clinic to assess first, especially regarding blood-thinning medication.

  • What are the warning signs of stroke?

    Sudden limb weakness, slurred speech, or facial drooping on one side — seek hospital care immediately.

  • Does Cheongdam Cell Clinic have a neurology department?

    The clinic's website does not indicate a dedicated neurology department or stroke-rehabilitation unit.

  • Can this programme replace post-stroke physical therapy?

    No. Physical and occupational therapy remain the core of recovery; this programme is only a supplement.

Medical cautions

5 points • reviewed 2026-08-28

Expand
  • This article is educational information only — not a diagnosis, prescription, or personal medical advice.
  • Outcomes vary by person, depending on age, underlying conditions, current medication, and the treating doctor's technique.
  • Consult a licensed physician and verify the clinic's licence before deciding on any treatment.
  • Some treatments (certain stem cell therapies in particular) are regulated differently by country — check Thai and Korean rules before travelling.
  • Prices, packages, and service details can change — confirm directly with the provider before paying.

Reviewed and last updated: 2026-08-28

References and sources

4 sources • every claim is traceable

Expand
  1. 1. Korea Ministry of Food and Drug Safety (MFDS)

    https://www.mfds.go.kr/eng/index.do

  2. 2. Korea Ministry of Health and Welfare (MOHW)

    https://www.mohw.go.kr/eng/

  3. 3. PubMed medical research database (NIH)

    https://pubmed.ncbi.nlm.nih.gov/

  4. 4. Medical Korea — official info for international patients (KHIDI)

    https://www.medicalkorea.or.kr/

Browse the full reference library →

Share this page

Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.

Back to categories
See all articles
See all in this category